Pain: Clinical Trials

910 trials for Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

637 completed, 96 unknown, 48 recruiting, 46 terminated. 910 Phase 1, 244 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 1910Completed 637, Unknown 96, Recruiting 48, Terminated 46, Withdrawn 28, Not yet recruiting 26, Active not recruiting 20, Enrolling by invitation 5, Suspended 4
Phase 2244Completed 149, Unknown 33, Recruiting 16, Withdrawn 14, Terminated 13, Not yet recruiting 10, Active not recruiting 7, Enrolling by invitation 1, Suspended 1

Follow Pain: new trials by email Literature Review of Pain trials Research Report on Pain

Trials (filtered) newest first · largest first

All 910 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
Coaching - Chronic Pain, Musculoskeletal Pain
Phase 1Not yet recruitingVA Office of Research and Development302029-01-012026-03-06
Psilocybin After Trauma Surgery for Pain
Psilocybin (Usona Institute), Postoperative analgesia - Pain Management, Postoperative Pain
Phase 1Not yet recruitingTrent Emerick702027-12-312026-08-06
Regenerative Medicine for Joint Hypermobility and Instability
Dextrose 20% Prolotherapy, Autologous Platelet-Rich Plasma, Doxycycline Hyclate Injectable (Investigational) - Ehlers-Danlos Syndrome Hypermobility Type (hEDS), Ehlers-Danlos Syndrome (EDS)
Phase 1 / Phase 2Not yet recruitingManhattan Pain Medicine, PLLC1002027-01-152026-10-06
Noninvasive Neuromodulation Of The Subjective Value Network In Chronic Pain
Transcranial magnetic stimulation, Sham - Chronic Neurogenic Pain
Phase 1Not yet recruitingNational Institute of Neurological Disorders and Stroke (NINDS)92026-12-012026-09-28
Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain
Resiniferatoxin - Intractable Pain, Palliative Care
Phase 1 / Phase 2Not yet recruitingNational Institute of Neurological Disorders and Stroke (NINDS)302026-11-272026-10-29
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
PFM-guided cortical stimulation - Neuropathic Pain, Postherpetic Neuralgia
Phase 1Not yet recruitingUniversity of Minnesota202026-11-012026-07-23
Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control After Pediatric Adenotonsillectomy
Celecoxib, Acetaminophen, Dexamethasone - Adenotonsillectomy, Postoperative Pain
Phase 1 / Phase 2Not yet recruitingNYU Langone Health5002026-11-012026-10-13
Buprenorphine for the Management of Pain in Children With Sickle Cell Disease
Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis
Phase 1Not yet recruitingNatasha Archer252026-10-012026-09-02
The Effect of Dexamethasone on Short Term Patient Response: IV vs Oral Administration
Dexamethasone IV injection, Dexamethasone Capsule, Placebo IV administration - Post Operative Pain, Acute, Periodontitis
Phase 1 / Phase 2Not yet recruitingThe University of Texas Health Science Center at San Antonio402026-10-012026-09-21
Vaginal Sildenafil for Primary Dysmenorrhea
Sildenafil citrate vaginal suppository - Dysmenorrhea, Menstrual Pain
Phase 1Not yet recruitingKevin Hellman102026-10-012026-09-25
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Intravenous Doses of NH302 Injection in Healthy Participants
NH302 injection, Placebo - Healthy Volunteers
Phase 1Not yet recruitingThe Third Xiangya Hospital of Central South University622026-09-302026-10-23
Daily, Encapsulated, Green Tea Extract to Mitigate Neuropathic Pain in Patients With Established Cancer-Associated Neuropathic Pain
Green Tea Leaf Extract Decaffeinated, Placebo Control - Neuropathic Pain, Cancer Treatment
Phase 1Not yet recruitingUniversity of Alabama at Birmingham202026-09-302026-08-21
A Study of CYT-1010 in Healthy Volunteers and Participants With Acute Pain After Third Molar Extraction
CYT-1010, Placebo - Acute Postoperative Pain, Dental Pain
Phase 1 / Phase 2RecruitingCytogel Pharma, LLC322026-09-252026-10-29
Long-acting Local Vaginal Cuff Anesthesia Following Hysterectomy
Combined Bupivacaine and Exparel, Normal Saline (NS) - Pain, Postoperative
Phase 1 / Phase 2Not yet recruitingThe University of Texas Health Science Center, Houston1042026-09-172026-09-25
Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
Fentanyl Citrate (Intranasal), Normal Saline (Placebo, Intranasal) - Neonatal Pain, Retinopathy of Prematurity (ROP)
Phase 1 / Phase 2Not yet recruitingMarsha Campbell-Yeo582026-09-092026-06-30
OER Glibenclamide for Neuropathic Pain in Multiple Sclerosis
glibenclamide, Placebo - Multiple Sclerosis, Neuropathic Pain
Phase 1Not yet recruitingUniversity of Maryland, Baltimore102026-09-012025-10-28
Psilocybin to Treat Depression in Spinal Cord Injury
Psilocybin (Usona Institute) - Spinal Cord Injury, Depression - Major Depressive Disorder
Phase 1 / Phase 2RecruitingJames J. Peters Veterans Affairs Medical Center302026-08-062026-08-10
Two Different Therapeutic Interventions Applied During Blood Sampling in Children
experimental group, experiment group, Control Group - Blood Sampling, Child, Only
Phase 1RecruitingIgdir University1052026-08-012026-09-09
A Study to Evaluate the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection in Participants With Moderate-to-Severe Non-Cancer Chronic Pain
KL0011034 injection, Alfentanil Hydrochloride Injection - Chronic Pain
Phase 1Not yet recruitingThe Third Xiangya Hospital of Central South University272026-07-302026-08-07
A Study Evaluating the Drug-Drug Interaction Between KL0011034 Injection and Alfentanil Hydrochloride Injection
KL0011034 injection, Alfentanil Hydrochloride Injection - Chronic Pain
Phase 1CompletedHunan Kelun Pharmaceutical Co., Ltd.272026-07-152026-09-17

Showing 20 of 910. Sign in to see all of them.

Narrower conditions

Pain, Postoperative (120)  ·  Chronic Pain (108)  ·  Neuralgia (70)  ·  Low Back Pain (55)  ·  Agnosia (50)  ·  Acute Pain (47)  ·  Headache (27)  ·  Back Pain (26)  ·  Neck Pain (22)  ·  Neoplasms (20)  ·  Opioid-Related Disorders (20)  ·  Osteoarthritis (20)  ·  Angina Pectoris (19)  ·  Abdominal Pain (15)

Broader conditions

Neurologic Manifestations (910)  ·  Pathological Conditions, Signs and Symptoms (910)  ·  Signs and Symptoms (910)  ·  Nervous System Diseases (226)  ·  Pathologic Processes (190)  ·  Postoperative Complications (125)  ·  Neuromuscular Diseases (118)  ·  Musculoskeletal Diseases (99)  ·  Peripheral Nervous System Diseases (98)  ·  Mental Disorders (65)  ·  Neurobehavioral Manifestations (59)  ·  Perceptual Disorders (54)  ·  Joint Diseases (53)  ·  Back Pain (52)

Interventions

Bupivacaine (30)  ·  Sodium Chloride (26)  ·  Saline Solution (25)  ·  Acetaminophen (24)  ·  Lidocaine (23)  ·  Ketamine (20)  ·  Oxycodone (19)  ·  Fentanyl (18)  ·  Ibuprofen (16)  ·  Morphine (16)  ·  Pregabalin (13)  ·  Acupuncture Therapy (12)  ·  Dexamethasone (12)  ·  Tramadol (12)  ·  Midazolam (11)

Sponsors

Vertex Pharmaceuticals Incorporated (25)  ·  Pfizer (22)  ·  GlaxoSmithKline (20)  ·  AstraZeneca (17)  ·  National Center for Complementary and Integrative Health (NCCIH) (11)  ·  Ain Shams University (10)  ·  Mayo Clinic (9)  ·  University of Florida (9)  ·  GrĂ¼nenthal GmbH (8)  ·  University of British Columbia (8)  ·  Assiut University (7)  ·  Bayer (7)  ·  Biogen (7)  ·  Johns Hopkins University (7)  ·  Mundipharma (China) Pharmaceutical Co. Ltd (7)

Countries

United States (385)  ·  Canada (52)  ·  United Kingdom (47)  ·  China (39)  ·  Egypt (32)  ·  Australia (31)  ·  Germany (24)  ·  South Korea (23)  ·  Israel (17)  ·  Belgium (16)  ·  Brazil (15)  ·  Denmark (15)  ·  Spain (15)  ·  France (14)  ·  Netherlands (14)

Top investigators

Ziva Cooper, PhD (4)  ·  Elisabeth Kruse, PhD (3)  ·  Keith M Vogt, MD, PhD (3)  ·  Rolf Karlsten (3)  ·  Simon Haroutounian, PhD (3)  ·  Stuart Kahn, MD (3)

Results publications

PMID 24666686, PMID 27893109, PMID 31005596, PMID 34145168, PMID 35295458, PMID 42712963, PMID 10084038, PMID 10353500, PMID 10360702, PMID 10488513, PMID 10870744, PMID 11145807, PMID 11165371, PMID 11172169, PMID 11427763, PMID 11786502, PMID 11892709, PMID 12384756, PMID 12615796, PMID 12709856, PMID 12779107, PMID 12897484, PMID 14563144, PMID 14621285, PMID 15115710, PMID 15454701, PMID 15647484, PMID 15677041, PMID 15800228, PMID 15922233, PMID 16153580, PMID 16192528, PMID 16227895, PMID 16371894, PMID 16466122, PMID 16508405, PMID 16595438, PMID 16880873, PMID 16894407, PMID 16911795, PMID 17123731, PMID 17237664, PMID 17256032, PMID 17342504, PMID 17433624, PMID 17513629, PMID 17562958, PMID 17635557, PMID 17853395, PMID 17895350

NIH funding

2014 (7), 2019 (3), 2008 (2), 2009 (2), 2015 (2), 2017 (2), K23DA029609 (2), R01MH134538 (2), R35GM146822 (2), 1IK2RX001136-01A2 (1), 1UG3DA049599 (1), 1UG3NS123965-01 (1), 2016 (1), 2018 (1), 2023 (1)